- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2014-10-07
2018-09-17
2018-09-17
200
NCT03077334
Yonsei University
Yonsei University
OBSERVATIONAL
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
The 18F-FDG-PET scan is currently being used for cancer diagnosis, staging, identifying hidden metastasis, and assessment of treatment responses in clinical oncology. Although there are important studies suggesting potential associations between PET-based parameters and oncologic outcomes, the calculation and official documentation of individual PET-based parameters might not be routine in clinical practice because these processes usually require time- and labor-consuming processes for the radiologists. In this study, the investigators prospectively determined clinical 18F-FDG-PET type according to degree of FDG-uptake in pancreatic cancer and compare oncologic outcomes between the types.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2017-02-20 | N/A | 2019-01-09 |
2017-03-09 | N/A | 2019-01-11 |
2017-03-10 | N/A | 2019-01 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : K-type FDG uptake in pancreatic cancer is similar to that of kidney | DEVICE: PET-CT
|
| : non K-type FDG uptake in pancreatic cancer is lower than that of kidney | DEVICE: PET-CT
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Clinical PET type assessed by surgeons from preoperatively preformed PET imaging | Three surgeons will review the preoperative PET imaging and each will determine the clinical PET type as either K-type or Non-K type. Inter-surgeon agreement of clinical PET type will be determined. Clinicopathologic characteristics between K-type and Non-K type will also be analyzed. | 1 week after surgery |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Number of patients with recurrence of cancer or mortality from cancer following operation | 3 years |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
20 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
